Systemic adverse effects and toxicities associated with immunotherapy: A review-Reference-Cited by-同舟云学术

Systemic adverse effects and toxicities associated with immunotherapy: A review

Published:2021-03-24 Issue:3 Volume:12 Page:150-163
ISSN:2218-4333
Container-title:World Journal of Clinical Oncology
language:
Short-container-title:WJCO

Author:

Kichloo Asim,Albosta Michael,Dahiya Dushyant,Guidi Jean Claude,Aljadah Michael,Singh Jagmeet,Shaka Hafeez,Wani Farah,Kumar Akshay,Lekkala Manidhar

Publisher

Baishideng Publishing Group Inc.

Subject

Oncology

Reference59 articles.

1. Enhancement of Antitumor Immunity by CTLA-4 Blockade

2. Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity

3. Cancer immunotherapy: harnessing the immune system to battle cancer

4. Lessons learned from the blockade of immune checkpoints in cancer immunotherapy

5. Cancer Research Institute. FDA Approval Timeline of Active Immunotherapies. [cited 13 January 2021]. Available from: https://www.cancerresearch.org/scientists/immuno-oncology-landscape/fda-approval-timeline-of-active-immunotherapies

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chrysin Enhances Anti‐Cancer Activity of Jurkat T Cell and NK‐92 Cells Against Human Breast Cancer Cell Lines;Chemistry & Biodiversity;2024-09-04

2. Applications of Multimodal Artificial Intelligence in Non-Hodgkin Lymphoma B Cells;Biomedicines;2024-08-05

3. Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT Interaction;The Journal of Physical Chemistry B;2024-07-03

4. A rare case of pneumocystosis under anti-PD-L1 therapy;Pulmonology;2024-07

5. Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation;Bioconjugate Chemistry;2024-05-24